Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 Jun;61(6):1602–1610. doi: 10.1172/JCI109080

Inherited Deficiency of the Seventh Component of Complement Associated with Nephritis

PROPENSITY TO FORMATION OF C5̄6̄ AND RELATED C7-CONSUMING ACTIVITY

G R Nemerow 1,2, H Gewurz 1,2, S G Osofsky 1,2, T F Lint 1,2
PMCID: PMC372686  PMID: 350902

Abstract

A 46-yr-old female with chronic pyelonephritis was found to lack complement (C) activity by the use of hemolytic screen assays in agarose gels. These assays also revealed a propensity of patient serum to form an activated complex of the fifth and sixth components of C, C5̄6̄. Each of the C component hemolytic activities was present in normal or elevated amounts with the exception of C7, which was undetectable; addition of purified C7 led to the restoration of hemolytic activity. C-dependent phagocytosis, immune adherence, and neutrophil chemotaxis were normal. Family studies demonstrated that the defect was transmitted as an autosomal codominant apparently not linked with alleles at the HLA-A or HLA-B loci. Persisting C5̄6̄ was readily formed in this as compared to normal serum upon incubation with multiple C activators including zymosan, inulin, immune complexes, heat-aggregated human gamma globulin, endotoxin, and agarose. A heat-stable (56°C, 30 min) activity which consumed C7 with time-and temperature-dependent kinetics was detected in plasma and serum, and seemed to be similar to a “C7 inactivator” previously described in another C7-deficient individual. However, this activity was found to have properties identical to those of C5̄6̄ during low ionic strength precipitation and chromatography on Sephadex G-200, to be specifically removed upon passage through an anti-C5 immunoadsorbent column, and to be associated with a small amount of C5̄6̄, suggesting that it represents an expression of small amounts of C5̄6̄ rather than a new C-inhibitory activity. Thus, an individual with chronic nephritis lacking C7 is reported; the utility of a hemolytic screen assay in agarose plates for the detection of such patients is emphasized; persisting C5̄6̄ is shown readily to be formed in this serum; and the presence of C7-consuming activity which is associated with and in all likelihood attributable to C5̄6̄ is shown.

Full text

PDF
1602

Images in this article

1605Image
on p.1605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson N., Alper C. A., Lachmann P. J., Rosen F. S., Jandl J. H. Deficiency of C3 inactivator in man. J Immunol. 1971 Jul;107(1):19–27. [PubMed] [Google Scholar]
  2. Alper C. A., Colten H. R., Gear J. S., Rabson A. R., Rosen F. S. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis. J Clin Invest. 1976 Jan;57(1):222–229. doi: 10.1172/JCI108263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alper C. A., Colten H. R., Rosen F. S., Rabson A. R., Macnab G. M., Gear J. S. Homozygous deficiency of C3 in a patient with repeated infections. Lancet. 1972 Dec 2;2(7788):1179–1181. doi: 10.1016/s0140-6736(72)92598-6. [DOI] [PubMed] [Google Scholar]
  4. Baker P. J., Lint T. F., Mortensen R. F., Gewurz H. C567-initiated cytolysis of lymphoid cells: description of the phenomenon and studies on its control by C567 inhibitors. J Immunol. 1977 Jan;118(1):198–202. [PubMed] [Google Scholar]
  5. Baker P. J., Rubin L. G., Lint T. F., McLeod B. C., Gewurz H. Binding of the complement intermediate C56 to zymosan in acute phase human sera. Clin Exp Immunol. 1975 Apr;20(1):113–124. [PMC free article] [PubMed] [Google Scholar]
  6. Ballow M., Shira J. E., Harden L., Yang S. Y., Day N. K. Complete absence of the third component of complement in man. J Clin Invest. 1975 Sep;56(3):703–710. doi: 10.1172/JCI108141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Boyer J. T., Gall E. P., Norman M. E., Nilsson U. R., Zimmerman T. S. Hereditary deficiency of the seventh component of complement. J Clin Invest. 1975 Oct;56(4):905–913. doi: 10.1172/JCI108170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Delâge J. M., Bergeron P., Simard J., Lehner-Netsch G., Prochazka E. Hereditary C7 deficiency. Diagnosis and HLA studies in a French-Canadian family. J Clin Invest. 1977 Nov;60(5):1061–1069. doi: 10.1172/JCI108857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gewurz A., Lint T. F., Roberts J. L., Zeitz H., Gewurz H. Homozygous C2 deficiency with fulminant lupus erythematosus: severe nephritis via the alternative complement pathway. Arthritis Rheum. 1978 Jan-Feb;21(1):28–36. doi: 10.1002/art.1780210106. [DOI] [PubMed] [Google Scholar]
  10. Goldlust M. B., Shin H. S., Hammer C. H., Mayer M. M. Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5. J Immunol. 1974 Sep;113(3):998–1007. [PubMed] [Google Scholar]
  11. Goldman J. N., Austen K. F. Reaction mechanisms of nascent C567 (reactive lysis). II. Killing of a rough form of Escherichia coli by C567, C8, and C9. J Infect Dis. 1974 Apr;129(4):444–450. doi: 10.1093/infdis/129.4.444. [DOI] [PubMed] [Google Scholar]
  12. Kitamura H., Matsumoto M., Inai S. Necessity of the divalent cation in the reaction between EAC1-8hu and C9gp. Int Arch Allergy Appl Immunol. 1976;51(2):265–271. doi: 10.1159/000231599. [DOI] [PubMed] [Google Scholar]
  13. Lachmann P. J., Thompson R. A. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med. 1970 Apr 1;131(4):643–657. doi: 10.1084/jem.131.4.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Leddy J. P., Frank M. M., Gaither T., Baum J., Klemperer M. R. Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies. J Clin Invest. 1974 Feb;53(2):544–553. doi: 10.1172/JCI107588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lim D., Gewurz A., Lint T. F., Ghaze M., Sepheri B., Gewurz H. Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis. J Pediatr. 1976 Jul;89(1):42–47. doi: 10.1016/s0022-3476(76)80924-9. [DOI] [PubMed] [Google Scholar]
  16. Miller M. E., Nilsson U. R. A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). N Engl J Med. 1970 Feb 12;282(7):354–358. doi: 10.1056/NEJM197002122820702. [DOI] [PubMed] [Google Scholar]
  17. Mittal K. K., Mickey M. R., Singal D. P., Terasaki P. I. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968 Nov;6(8):913–927. doi: 10.1097/00007890-196811000-00006. [DOI] [PubMed] [Google Scholar]
  18. NISHIOKA K. Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence. J Immunol. 1963 Jan;90:86–97. [PubMed] [Google Scholar]
  19. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  20. Nilsson U. R., Miller M. E., Wyman S. A functional abnormality of the fifth component of complement (C5) from human serum of individuals with a familial opsonic defect. J Immunol. 1974 Mar;112(3):1164–1176. [PubMed] [Google Scholar]
  21. Petersen B. H., Graham J. A., Brooks G. F. Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity. J Clin Invest. 1976 Feb;57(2):283–290. doi: 10.1172/JCI108279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rittner C., Opferkuch W., Wellek B., Grosse-Wilde H., Wernet P. Lack of linkage between gene(s) controlling the synthesis of the seventh component of complement and the HLA region on chromosome No. 6 in man. Hum Genet. 1976 Oct 28;34(2):137–142. doi: 10.1007/BF00278881. [DOI] [PubMed] [Google Scholar]
  23. Rosenfeld S. I., Baum J., Steigbigel R. T., Leddy J. P. Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum. J Clin Invest. 1976 Jun;57(6):1635–1643. doi: 10.1172/JCI108434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Thompson R. A., Lachmann P. J. A second case of human C3b inhibitor (KAF) deficiency. Clin Exp Immunol. 1977 Jan;27(1):23–29. [PMC free article] [PubMed] [Google Scholar]
  25. Thompson R. A., Rowe D. S. Reactive haemolysis--a distinctive form of red cell lysis. Immunology. 1968 May;14(5):745–762. [PMC free article] [PubMed] [Google Scholar]
  26. Wellek B., Opferkuch W. A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle. Clin Exp Immunol. 1975 Feb;19(2):223–235. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES